Influences of PC cell-derived growth factor and breast cancer resistance protein on the curative effects of platinum-based chemotherapeutic regimens for advanced non-small cell lung cancer

National Medical Journal of China

Volumn 86, Issue 37, 2006, Pages 2611-2614

  Hu, Yi ^a   Lin, Dong Mei ^b   Cheng, Shu Jun ^b   Liu, You Ning ^b   Feng, Feng Yi ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NONE

Author keywords

Cancer, non small cell of lung; Chemotherapy, combine; Prediction

Indexed keywords

BIOLOGICAL MARKER; BREAST CANCER RESISTANCE PROTEIN; PLATINUM COMPLEX; PROGRANULIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CANCER TISSUE; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROTEIN EXPRESSION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING;

EID: 33845867412     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 2000. CA Cancer J Clin, 2000, 50:7-33.
2. Chinese source. 2002, 29:197-201.
3. Chinese source. 2004,84:663-666.
4. Scheffer GL, Maliepaard M, Pijnenborg ACLM, et al. Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistance cell lines. Cancer Res, 2000, 60:2589-2593.
5. Tangkeangsirisin W, Hayashi J, Serrero G. PC cell-derived growth factor mediates tamoxifen resistance and promotes tumor growth of human breast cancer cells. Cancer Res, 2004, 64:1737-1743.
6. Zhou J, Gao G, Crabb JW, et al. Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line. J Biol Chem, 1993, 268:10863-10869.
7. Tangkeangsirisin W, Serrero G. PC cell-derived growth factor (PCDGF/ GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis, 2004, 25:1587-1592.
8. Ross DD, Yang W, Abruzzo LV, et al. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst, 1999, 91: 429-433.
9. Maliepaard M, van Gastelen MA, de Jong LA, et al. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res, 1999, 59:4559-4563.
10. Doyle A, Yang W. Chinese source. 2001, 20:274-278.
11. Yoh K, Ishii G, Yokose T, et al. Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer. Clin Cancer Res, 2004, 10: 1691-1697.